Navigation Links
Gentamicin Sulfate: Liquid

ProductsGentamicin Sulfate: Liquid
Company CellGro by Mediatech
Item Gentamicin Sulfate: Liquid
Features 
Description Gentamycin sulfate is effective against gram positive and gram negative bacteria, as well as mycoplasma, by interfering with bacterial protein synthesis by binding to the 30S subunit of ribosomes. Its suggested working concentration of 50 mg/L is generally non-toxic to viruses and mammalian cells, thereby making a gentler alternative to penicillin and steptomycin. While it is useful for treating persistent contaminants, it is also beneficial for extended virus and tissue culture studies due to the slow development of bacterial resistance and for protein studies due to its lack of protein binding. It is also generally more stable at room temperature than other antibiotics. The sterile solution is prepared in water at a concentration of 50 mg/mL and a stock solution prepared from the powder should be prepared similarly.
Info CellGro by Mediatech
Customer Service: (800) CELLGRO
Web site: http://www.cellgro.com

Related medicine products :

1. Gentamicin
2. Gibco Gentamicin Reagent Solution (10 mg/ml) liquid
3. Gibco Gentamicin Reagent Solution (50 mg/ml), liquid
4. Gibco Gentamicin Reagent Solution (50 mg/ml) liquid
5. Gentamicin Sulphate
6. Gentamicin Sulfate
7. Gentamicin, 50 mg/ml crimp cap
8. Gentamicin, 50 mg/ml
9. Gentamicin, 10 mg/ml
10. Palacos® G Bone Cement with Gentamicin
11. Depuy 1 Gentamicin Bone Cement
10 mm angled tip with indentation on side and gently curved blade. Round knurled handle with polished finish. Indentation: left side....
Angled tip with gently curved blade. Short hexagonal handle with polished finish. 0.5 mm x 15 mm tip....
Used to rotate or stabilize nucleus during phacoemulsification. Also used to retract the iris and capsule facilitating access to cortex caught in the superior capsular cul-de-sac. Round knurled handl...
The popular Bechert nucleus rotator has been modified to have the shaft angled 10 mm from tip to bend for ease of manipulation of the lens nucleus in the anterior chamber. Round knurled handle....
Medicine Products:
(Date:6/24/2017)... Tampa, Fla. (PRWEB) , ... June 24, 2017 ... ... Fla., is now offering genetic testing for medications in select Florida and Texas ... of pharmacogenomics. , This new application of genetic testing recognizes the role ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island ... Care Management Alerts and Dashboards, an innovative new service enabling healthcare providers to ... Care Management Alerts and Dashboards provide near real-time data about patients admitted to ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Military Officers Association of America (MOAA) announced ... Veterans Affairs, retired Marine Col. Thomas G. Bowman. , Bowman currently serves as the ... an intimacy with the issues and challenges veterans face with the VA. Following a ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... The Aesthetic ... facelift . Dr. Talei has come up with a proprietary technique that he calls ... lifts tissues that have dropped. For all ages, patients can expect to look refreshed, ...
(Date:6/23/2017)... Santa Monica, CA (PRWEB) , ... June 23, 2017 , ... ... PureLife as the endorsed amalgam separator supplier for CDA members. As part of the ... a reduced price of $99, saving more than $400 off the retail value. This ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... ALTO, Calif. , June 9, 2017 ... device company focused on the design, manufacture, sale and ... the market on the progress of its commercial roll-out ... is now available in more than one hundred (100) ... AeroForm offers a needle-free alternative for ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: